Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $207.4300 (2.8%) ($207.4300 - $207.4300) on Mon. Feb. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 87 | Latest Price | $207.4300(2.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 3.1% a day on average for past five trading days. | Weekly Trend | LGND advances 15% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) IWM(53%) IWC(52%) XBI(52%) | Factors Impacting LGND price | LGND will decline at least -2.035% in a week (0% probabilities). VIXM(-26%) UUP(-18%) VXX(-16%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $188.76(9.89%) | 10 Day Moving Average | $183.06(13.31%) | 20 Day Moving Average | $156.86(32.24%) | To recent high | 0% | To recent low | 154.8% | Market Cap | $3.334b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |